Literature DB >> 34551328

Stem cells immortalized by hTERT perform differently from those immortalized by SV40LT in proliferation, differentiation, and reconstruction of matrix microenvironment.

Yiming Wang1, Yixuan Amy Pei2, Yuan Sun3, Sheng Zhou3, Xiao-Bing Zhang4, Ming Pei5.   

Abstract

Although matrix microenvironment has the potential to improve expanded stem cell proliferation and differentiation capacity, decellularized extracellular matrix (dECM) deposited by senescent cells does not contribute to the rejuvenation of adult stem cells, which has become a barrier to personalized stem cell therapy. Genetic modification is an effective strategy to protect cells from senescence but it carries the increased risk of malignant transformation and genetic instability. In this study, lentivirus carrying either human telomerase reverse transcriptase (hTERT) or simian virus 40 large T antigen (SV40LT) was used to transduce human infrapatellar fat pad-derived stem cells (IPFSCs). We found that virus transduction modified the proliferative, chondrogenic, and adipogenic abilities of IPFSCs. Interestingly, dECM deposited by immortalized cells significantly influenced replicative senescent IPFSCs in proliferation and differentiation preference, the effect of which is hinged on the approach of immortalization using either SV40LT or hTERT. Our findings indicate both dECM expansion and immortalization strategies can be used for replicative senescent adult stem cells' proliferation and lineage-specific differentiation, which benefits future stem cell-based tissue regeneration. This approach may also work for adult stem cells with premature senescence in elderly/aged patients, which needs further investigation. STATEMENT OF SIGNIFICANCE: Adult stem cells are a promising solution for autologous cell-based therapy. Unfortunately, cell senescence due to donor age and/or ex vivo expansion prevents clinical application. Recent progress with decellularized extracellular matrix provides a potential for the rejuvenation of senescent stem cells by improving their proliferation and differentiation capacities. Given the fact that the young matrix can provide a healthy and energetic microenvironment, in this study, two approaches using lentivirus transduction of hTERT and SV40LT were compared. The goal was to immortalize donor cells for deposition of decellularized extracellular matrix. The matrix was demonstrated to contribute diverging effects on the chondrogenic and adipogenic differentiation of expanded stem cells and exhibited proliferation benefits as well. These findings provide an invaluable asset for stem cell-based tissue regeneration.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Adipogenic differentiation; Chondrogenic differentiation; Decellularized extracellular matrix; Infrapatellar fat pad-derived stem cells; Proliferation; SV40LT; hTERT

Mesh:

Substances:

Year:  2021        PMID: 34551328      PMCID: PMC8627502          DOI: 10.1016/j.actbio.2021.09.021

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  66 in total

1.  Effects of ectopic Nanog and Oct4 overexpression on mesenchymal stem cells.

Authors:  Tong Ming Liu; Ying Nan Wu; Xi Min Guo; James Hoi Po Hui; Eng Hin Lee; Bing Lim
Journal:  Stem Cells Dev       Date:  2009-09       Impact factor: 3.272

2.  Differentiation of human adipose-derived stem cells into fat involves reactive oxygen species and Forkhead box O1 mediated upregulation of antioxidant enzymes.

Authors:  Masayoshi Higuchi; Gregory J Dusting; Hitesh Peshavariya; Fan Jiang; Sarah Tzu-Feng Hsiao; Elsa C Chan; Guei-Sheung Liu
Journal:  Stem Cells Dev       Date:  2012-11-12       Impact factor: 3.272

Review 3.  A review of decellularized stem cell matrix: a novel cell expansion system for cartilage tissue engineering.

Authors:  M Pei; J T Li; M Shoukry; Y Zhang
Journal:  Eur Cell Mater       Date:  2011-11-24       Impact factor: 3.942

4.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

5.  SIRT1-dependent anti-senescence effects of cell-deposited matrix on human umbilical cord mesenchymal stem cells.

Authors:  Long Zhou; Xi Chen; Tao Liu; Caihong Zhu; Michelle Si; Joseph Jargstorf; Mao Li; Guoqing Pan; Yihong Gong; Zong-Ping Luo; Huilin Yang; Ming Pei; Fan He
Journal:  J Tissue Eng Regen Med       Date:  2017-06-20       Impact factor: 3.963

6.  Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication.

Authors:  A B Niculescu; X Chen; M Smeets; L Hengst; C Prives; S I Reed
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

7.  Downregulation of Melanoma Cell Adhesion Molecule (MCAM/CD146) Accelerates Cellular Senescence in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells.

Authors:  Hye Jin Jin; Ji Hye Kwon; Miyeon Kim; Yun Kyung Bae; Soo Jin Choi; Wonil Oh; Yoon Sun Yang; Hong Bae Jeon
Journal:  Stem Cells Transl Med       Date:  2016-03-03       Impact factor: 6.940

8.  Culturing on decellularized extracellular matrix enhances antioxidant properties of human umbilical cord-derived mesenchymal stem cells.

Authors:  Xiaozhen Liu; Long Zhou; Xi Chen; Tao Liu; Guoqing Pan; Wenguo Cui; Mao Li; Zong-Ping Luo; Ming Pei; Huilin Yang; Yihong Gong; Fan He
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2015-12-30       Impact factor: 7.328

9.  Spatiotemporal profile of N-cadherin expression in the developing limb mesenchyme.

Authors:  S A Oberlender; R S Tuan
Journal:  Cell Adhes Commun       Date:  1994-12

10.  Matrix reverses immortalization-mediated stem cell fate determination.

Authors:  Yiming Wang; Gangqing Hu; Ryan C Hill; Monika Dzieciatkowska; Kirk C Hansen; Xiao-Bing Zhang; Zuoqin Yan; Ming Pei
Journal:  Biomaterials       Date:  2020-09-16       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.